RAS, MYC, and sensitivity to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis -: Response

被引：0
作者：
Nesterov, A [1 ]
Kraft, AS [1 ]
机构：
[1] Med Univ S Carolina, Med Ctr, Hollings Canc Ctr, Charleston, SC 29425 USA
来源：
CANCER RESEARCH | 2005年 / 65卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1616 / 1617
页数：2
相关论文
共 50 条
  • [41] Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
    Koschny, Ronald
    Holland, Heidrun
    Sykora, Jaromir
    Haas, Tobias L.
    Sprick, Martin R.
    Ganten, Tom M.
    Krupp, Wolfgang
    Bauer, Manfred
    Ahnert, Peter
    Meixensberger, Juergen
    Walczak, Henning
    CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3403 - 3412
  • [42] The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis
    Michowitz, Y
    Goldstein, E
    Roth, A
    Afek, A
    Abashidze, A
    Ben Gal, Y
    Keren, G
    George, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) : 1018 - 1024
  • [43] Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation
    Xie, LX
    Shi, WY
    Guo, P
    TRANSPLANTATION, 2003, 76 (11) : 1556 - 1559
  • [44] Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic pathways in cancer immunosurveillance: molecular mechanisms and prospects for therapy
    James, Britnie R.
    Griffith, Thomas S.
    RESEARCH AND REPORTS IN BIOCHEMISTRY, 2015, 5 : 1 - 10
  • [45] Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells
    Oka, N
    Nakahara, S
    Takenaka, Y
    Fukumori, T
    Hogan, V
    Kanayama, F
    Yanagawa, T
    Raz, A
    CANCER RESEARCH, 2005, 65 (17) : 7546 - 7553
  • [46] Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor related apoptosis-inducing ligand receptor 2
    Motoki, K
    Mori, E
    Matsumoto, A
    Thomas, M
    Tomura, T
    Humphreys, R
    Albert, V
    Muto, M
    Yoshida, H
    Aoki, M
    Tamada, T
    Kuroki, R
    Yoshida, H
    Ishida, I
    Ware, CF
    Kataoka, S
    CLINICAL CANCER RESEARCH, 2005, 11 (08) : 3126 - 3135
  • [47] Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes
    Simon, AK
    Williams, O
    Mongkolsapaya, J
    Jin, B
    Xu, XN
    Walczak, H
    Screaton, GR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) : 5158 - 5163
  • [48] Mechanisms of sensitivity and resistance of melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
    Kurbanov, B. M.
    Fecker, L. F.
    Sterry, W.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 263 - 263
  • [49] Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
    Leverkus, M
    Neumann, M
    Mengling, T
    Rauch, CT
    Bröcker, EB
    Krammer, PH
    Walczak, H
    CANCER RESEARCH, 2000, 60 (03) : 553 - 559
  • [50] Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Nguyen, T
    Zhang, XD
    Hersey, P
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 966S - 973S
12345